Showing results (11-20 of 1,305) with videos related to

Sort By:
Pageof 131
Journal of the American College of Cardiology|October 29, 2011
Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudyPatrick Rossignol, Joël Ménard, Renaud Fay, et al.
European Journal of Heart Failure|April 13, 2017
Tailoring mineralocorticoid receptor antagonist therapy in heart failure patients: are we moving towards a personalized approach?João Pedro Ferreira, Robert J Mentz, Anne Pizard, et al.
Cardiology|July 19, 2006
FDA and CPMP rulings on subgroup analysesAldo P Maggioni, Bernadette Darne, Dan Atar, et al.
Trends in Endocrinology and Metabolism: TEM|February 25, 2015
Emerging cardiovascular indications of mineralocorticoid receptor antagonistsYasir Parviz, Javaid Iqbal, Bertram Pitt, et al.
European Heart Journal|April 11, 2025
Aldosterone-targeted therapies: early implementation in resistant hypertension and chronic kidney diseaseMasatake Kobayashi, Bertram Pitt, João Pedro Ferreira, et al.
International Journal of Cardiology|August 2, 2008
Low serum magnesium and cardiovascular mortality in chronic heart failure: a propensity-matched studyChris Adamopoulos, Bertram Pitt, Xuemei Sui, et al.
JACC. Heart Failure|November 7, 2015
Prognostic Value of Estimated Plasma Volume in Heart FailureKévin Duarte, Jean-Marie Monnez, Eliane Albuisson, et al.
JACC. Heart Failure|July 2, 2025
Interaction Between Aldosterone and Mineralocorticoid Receptor Antagonist: Findings From the EPHESUS TrialMasatake Kobayashi, Bertram Pitt, João Pedro Ferreira, et al.
European Journal of Heart Failure|January 28, 2014
Selection of a mineralocorticoid receptor antagonist for patients with hypertension or heart failureJavaid Iqbal, Yasir Parviz, Bertram Pitt, et al.
International Journal of Cardiology|April 18, 2009
Transatlantic similarities and differences in major natural history endpoints of heart failure after acute myocardial infarction: a propensity-matched study of the EPHESUS trialBertram Pitt, Faiez Zannad, Mihai Gheorghiade, et al.
Pageof 131